RUNX3 Gene Methylation in Epithelial Ovarian Cancer Tissues and Ovarian Cancer Cell Lines
Authors:
- 1 August 2009
- journal article
- research article
- Published by SAGE Publications in OMICS: A Journal of Integrative Biology
- Vol. 13 (4) , 307-311
Abstract
Methylation plays an important role in the regulation of gene expression in many cancer tissues. RUNX3 is an important tumor suppressor gene located on human chromosome 1p36.1, and many tumors do not express it due to methylation of the promoter region of the CpG island. The molecular mechanisms involved in RUNX3 gene expression and epithelial ovarian cancer are not fully understood. This study investigates the relationship between RUNX3 methylation and expression in ovarian cancer. The methylation of the RUNX3 gene promoter region was measured in 32 primary epithelial ovarian cancer samples and corresponding nonmalignant ovarian tissues, 36 benign epithelial ovarian tumor tissues, and 10 normal ovarian tissues by methylation-specific PCR (MSP) and RT-PCR. The relationships between RUNX3 methylation status, expression, and clinicopathologic characteristics were analyzed. RUNX3 methylation was further assessed by MSP and RT-PCR before and after 5-aza-2′-deoxycytidine (5-aza-dc) treatment in normal and cancer cell lines. We detected RUNX3 methylation in 53.1% of primary ovarian cancer tumors, 16.7% of benign ovarian tumors, and 28% of nonmalignant tissues surrounding ovarian cancers. No methylation was detected in normal ovarian tissues. No significant correlation between RUNX3 methylation and clinicopathological characteristics was observed. The RT-PCR results found RUNX3 expression in all normal ovarian tissues (10/10) and in most of the unmethylated ovarian cancer tissues (12/15); in contrast, it was not detected in most of the RUNX3 -methylated ovarian cancer tissues (16/17). Our data suggest that methylation plays a critical role in the regulation of RUNX3 repression, and that it is significantly correlated with RUNX3 mRNA expression in ovarian cancer tissues ( p = 0.006).Keywords
This publication has 24 references indexed in Scilit:
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- RUNX3 Inactivation by Point Mutations and Aberrant DNA Methylation in Bladder TumorsCancer Research, 2005
- Hypermethylation of the RUNX3 gene in hepatocellular carcinomaExperimental & Molecular Medicine, 2005
- Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinomaLiver International, 2005
- Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancerGynecologic Oncology, 2004
- Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancersInternational Journal of Cancer, 2004
- Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinomaCancer, 2003
- Hypermethylation of the RUNX3 Gene Promoter in Testicular Yolk Sac Tumor of InfantsThe American Journal of Pathology, 2003
- Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumoursOncogene, 2001
- Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristicsOncogene, 1999